GlassScriptPhysician profile
Hasan A Ahmad
NPI 1255478517
$25,147.41
in general payments reported to CMS, 2019-2025
21 companies · $4,190 in 2025
The $4,190 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,637 · 2020: $389 · 2021: $1,710 · 2022: $5,842 · 2023: $7,423 · 2024: $3,957 · 2025: $4,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $4,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,373.90 |
| Food and Beverage | $4,195.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $13,025.28 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $3,149.42 | 2019-2025 | Mitraclip, Triclip, Jot Dx |
| Angiodynamics, INC. | $2,188.22 | 2025 | Angiovac, Alphavac |
| Medtronic, INC. | $1,864.58 | 2023-2024 | Corevalve Evolut R, Abre |
| Boston Scientific Corporation | $1,736.06 | 2019-2023 | Lux-Dx Insertable Cardiac Monitor |
| Medtronic Vascular, INC. | $620.02 | 2019-2020 | |
| Abiomed | $552.58 | 2021-2024 | Impella |
| Novartis Pharmaceuticals Corporation | $319.73 | 2019-2025 | |
| Chiesi USA, INC. | $304.24 | 2019-2025 | Kengreal |
| Inari Medical, INC. | $298.17 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $220.77 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Stryker Corporation | $191.18 | 2025 | Clottriever Bold Catheter, Flowtriever |
| Endologix LLC | $150.00 | 2025 | Endocross Device, Torus Stent Graft System |
| Biocomposites INC | $145.15 | 2025 | Stimulan |
| W. L. Gore & Associates, INC. | $132.26 | 2019-2023 | Gore Cardioform Septal Occluder |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $117.74 | 2021 | |
| Philips North America LLC | $55.57 | 2019-2022 | |
| Cardiva Medical, INC. | $23.61 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Penumbra, INC. | $21.32 | 2024 | Indigo System |
| Recor Medical INC | $18.91 | 2025 | Paradise Ultrasound Renal Denervation System |
| Abbvie INC. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hasan Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.